Filtered By:
Specialty: Cardiology
Condition: Patent Foramen Ovale
This page shows you your search results in order of relevance. This is page number 14.
Order by Relevance | Date
Total 614 results found since Jan 2013.
Localization of Infratentorial Lesion could Predict Patent Foramen Ovale as an Etiology in Embolic Stroke of Undetermined Source
CONCLUSIONS: Infratentorial lesions may be independently associated with PFO in patients with ESUS. The presence of infratentorial lesions could predict the presence of PFO in ESUS cases.PMID:33952811 | DOI:10.5551/jat.61200
Source: Journal of Atherosclerosis and Thrombosis - May 6, 2021 Category: Cardiology Authors: Kentaro Ishizuka Sono Toi Takao Hoshino Eiko Higuchi Kazuo Kitagawa Source Type: research
Patent foramen ovale channel morphometric characteristics associated with cryptogenic stroke – the MorPFO score.
It is still disputable whether the specific morphological properties of the patent foramen ovale (PFO) may contribute to the occurrence of stroke. The aim of this study was to evaluate the differences in the morphometric and functional features of the PFO channel in cryptogenic stroke and non-stroke patients.
Source: Journal of the American Society of Echocardiography - August 10, 2021 Category: Cardiology Authors: Mateusz K. Ho łda, Agata Krawczyk-Ożóg, Mateusz Koziej, Joanna Kołodziejczyk, Danuta Sorysz, Elżbieta Szczepanek, Justyna Jędras, Dariusz Dudek Tags: Clinical Investigations Source Type: research
Patent Foramen Ovale Channel Morphometric Characteristics Associated with Cryptogenic Stroke: The MorPFO Score
It is still disputable whether the specific morphologic properties of patent foramen ovale (PFO) may contribute to the occurrence of stroke. The aim of this study was to evaluate the differences in the morphometric and functional features of the PFO channel in patients with cryptogenic stroke and those without stroke.
Source: Journal of the American Society of Echocardiography - August 10, 2021 Category: Cardiology Authors: Mateusz K. Ho łda, Agata Krawczyk-Ożóg, Mateusz Koziej, Joanna Kołodziejczyk, Danuta Sorysz, Elżbieta Szczepanek, Justyna Jędras, Dariusz Dudek Tags: Clinical Investigations Source Type: research
Cost-effectiveness analysis of patent foramen ovale closure with Amplatzer plus medical therapy compared to medical therapy in patients with a history of stroke in France
CONCLUSION: Amplatzer plus MT represents a cost-effective treatment option and is associated with lower stroke recurrence compared to MT alone for PFO patients with a prior history of stroke.PMID:34772575 | DOI:10.1016/j.jjcc.2021.10.009
Source: Journal of Cardiology - November 13, 2021 Category: Cardiology Authors: Amel Allou Louise Baschet Charles Sabourin Gilles Montalscot Luc Lorgis Xavier Iriart Source Type: research
Cryptogenic Ischemic Stroke in Migraine: Role of Patent Foramen Ovale
CONCLUSION: In a young adult population with CIS, MWA was strongly associated with possibly causal PFO, i.e., with a large shunt or combined with an interatrial septal aneurysm.PMID:35295806 | PMC:PMC8915651 | DOI:10.3389/fpain.2022.823595
Source: Atherosclerosis - March 17, 2022 Category: Cardiology Authors: C édric Gollion Fleur Lerebours Marianne Barbieux-Guillot Vincent Fabry Vincent Larrue Source Type: research
Net clinical benefit of PFO closure versus medical treatment in patients with cryptogenic stroke: A systematic review and meta-analysis
CONCLUSION: The NCB between PFO closure and medical treatment was not different, suggesting individualized treatment to maximize benefit.PMID:36584788 | DOI:10.1016/j.hjc.2022.12.010
Source: Hellenic Journal of Cardiology - December 30, 2022 Category: Cardiology Authors: Konstantinos Kolokathis Costas Thomopoulos Konstantinos Tsioufis Source Type: research
Patent Foramen Ovale-associated Stroke and COVID-19 Vaccination
Case –control studies have shown an association between patent foramen ovale (PFO) and cryptogenic stroke, which was observed particularly in patients younger than 55 years without conventional risk factors. The role of PFO closure in preventing stroke recurrence had been uncertain for many years, unt il four randomised clinical trials in 2017 and 2018 unequivocally demonstrated a benefit, with the number needed t...
Source: Radcliffe Cardiology - April 5, 2023 Category: Cardiology Authors: c242508f1d9059bc0f2aa9bdd5421ba2 Source Type: research
Dual potential embolic source detected in left atrium during hyperacute stroke
Clinical introduction A woman in her late 60s with a medical history of hypertension presented to the emergency department with symptoms of a stroke which began 40 min prior. Brain MRI was performed (figure 1A). Hyperacute CT angiography of the head and neck did not find any atherosclerosis. ECG is shown (figure 1B), and subsequent transthoracic echocardiography showed left atrium enlargement and left-to-right flow at the region of the fossa ovalis (figure 1C). Figure 1Brain MRI of diffusion-weighted image sequence (A), ECG (B), and transthoracic echocardiogram (C). Question Which of the following is the most likely mechan...
Source: Heart - September 13, 2023 Category: Cardiology Authors: Fu, Z., Xu, C., Gao, L. Tags: Image challenges Source Type: research
Ischemic stroke and incidental finding of a right atrial lipoma
A young man presented with recurrent ischemic stroke under antiplatelet therapy. A patent foramen ovale (PFO) was diagnosed by transesophageal echocardiography (TEE) and the patient was referred to our institution for percutaneous closure. An echogenic mass in the right atrium was detected during the intraprocedural TEE. The interventional team decided to perform transcatheter closure of PFO under fluoroscopy and TEE guide, without complications. Subsequent cardiac magnetic resonance (CMR) imaging confirmed an encapsulated and hyperintense mass located in the roof of the right atrium. The signal intensity pattern and the a...
Source: Journal of Cardiovascular Medicine - November 5, 2013 Category: Cardiology Tags: Images in cardiovascular medicine Source Type: research
Simultaneous onset of myocardial infarction and ischemic stroke in a patient with atrial fibrillation: Multiple territory injury revealed on angiography and magnetic resonance
An 84-year-old man with a history of hypertension and paroxysmal atrial fibrillation (AF) who received no anticoagulant drugs experienced acute chest pain and transient loss of consciousness. He was transferred to our emergency room. His initial electrocardiogram showed sinus rhythm with ST-segment elevation in the I, aVL, and V1–V6 leads. His blood pressure was 158/92mmHg and his pulse was regular at 70beats per minute. A chest radiograph showed increased heart size and pulmonary vascular congestion. His troponin T level was elevated (more than 0.1ng/mL). He was diagnosed with ST-elevation myocardial infarction (MI) and...
Source: International Journal of Cardiology - February 4, 2014 Category: Cardiology Authors: Osamu Hashimoto, Kozo Sato, Yohei Numasawa, Joji Hosokawa, Masahiro Endo Tags: Online Letters to the Editor Source Type: research
Transesophageal echocardiography in patients with cryptogenic ischemic stroke: A systematic review
Conclusions Routine TEE in patients with cryptogenic IS identifies cardiac findings in a large proportion. However, there is marked interstudy variation in the definition and prevalence of common findings. Transesophageal echocardiography–detected findings prompted the introduction of anticoagulant therapy in up to one-third of patients. However, these were mostly not for established guideline-based indications based on randomized controlled trial evidence. It is unclear if routine use of TEE in patients with cryptogenic IS is indicated.
Source: American Heart Journal - October 31, 2014 Category: Cardiology Source Type: research
Meta-analysis of Net Long-term Benefit of Different Therapeutic Strategies in Patients with Cryptogenic Stroke and Patent Foramen Ovale
We pooled available data on follow-up events in patients with patent foramen ovale and cryptogenic stroke to evaluate the net clinical benefit of different therapeutic strategies (percutaneous closure vs antiplatelet vs anticoagulant therapy). MEDLINE/Pubmed and Cochrane databases and reviewed cited references to identify relevant studies were used; 3,311 patients from 21 clinical studies, both observational and randomized, with follow-up ≥12 months were overall included. Net clinical benefit was evaluated considering the cumulative incidence of both stroke/transient ischemic attack and major bleeding events.
Source: The American Journal of Cardiology - January 5, 2015 Category: Cardiology Authors: Giuseppe Patti, Francesco Pelliccia, Carlo Gaudio, Cesare Greco Source Type: research
